Zenas BioPharma, Inc.
ZBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001953926
No open-market purchases or sales by Zenas BioPharma, Inc. insiders were filed in the last 90 days; 144 institutions reported holding it in 13F filings for Q2 2026, worth $1.55B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Zenas BioPharma, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- +44 vs. Q2 2024
- Shares held
- 24.8M
- +24.8M vs. Q2 2024
- Total value
- $418.5M
- +$418.5M vs. Q2 2024
- New holders
- 44
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 144 | $1.55B |
| Q1 2026 | 140 | $1.14B |
| Q4 2025 | 119 | $1.55B |
| Q3 2025 | 80 | $774.5M |
| Q2 2025 | 73 | $330.0M |
| Q1 2025 | 67 | $256.7M |
| Q4 2024 | 65 | $259.6M |
| Q3 2024 | 44 | $418.5M |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Zenas BioPharma, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MRP Capital Investments, LLC | 35 | $593 | 0.00% | +35 | New |
| UBS Group AG | 59 | $998 | 0.00% | +59 | New |
| Aster Capital Management (DIFC) Ltd | 3,018 | $51.1K | 0.01% | +3,018 | New |
| Cubist Systematic Strategies, LLC | 3,762 | $63.7K | 0.00% | +3,762 | New |
| The PNC Financial Services Group, Inc. | 3,849 | $65.1K | 0.00% | +3,849 | New |
| Landscape Capital Management, L.L.C. | 10,074 | $170.5K | 0.02% | +10,074 | New |
| Capula Management Ltd | 10,615 | $179.6K | 0.00% | +10,615 | New |
| Two Sigma Investments, LP | 13,000 | $220.0K | 0.00% | +13,000 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 13,529 | $228.9K | 0.04% | +13,529 | New |
| HRT Financial LP | 15,463 | $261.0K | 0.00% | +15,463 | New |
| Barclays PLC | 15,500 | $262.3K | 0.00% | +15,500 | New |
| Geode Capital Management, LLC | 24,857 | $420.6K | 0.00% | +24,857 | New |
| M&T Bank Corp | 24,884 | $421.5K | 0.00% | +24,884 | New |
| Point72 (DIFC) Ltd | 26,129 | $442.1K | 0.03% | +26,129 | New |
| Teachers Retirement System of the State of Kentucky | 27,880 | $472.0K | 0.00% | +27,880 | New |
| Maven Securities LTD | 31,054 | $525.4K | 0.06% | +31,054 | New |
| Squarepoint Ops LLC | 32,299 | $546.5K | 0.00% | +32,299 | New |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 37,500 | $634.5K | 0.01% | +37,500 | New |
| Morgan Stanley | 51,050 | $863.8K | 0.00% | +51,050 | New |
| Point72 Asset Management, L.P. | 57,600 | $974.6K | 0.00% | +57,600 | New |
| Norges Bank | 75,000 | $1.27M | 0.00% | +75,000 | New |
| Standard Life Aberdeen plc | 75,100 | $1.27M | 0.00% | +75,100 | New |
| Citadel Advisors LLC | 94,322 | $1.60M | 0.00% | +94,322 | New |
| Superstring Capital Management LP | 111,605 | $1.89M | 1.69% | +111,605 | New |
| Millennium Management LLC | 117,381 | $1.99M | 0.00% | +117,381 | New |
| Goldman Sachs Group Inc | 132,400 | $2.24M | 0.00% | +132,400 | New |
| Vanguard Group Inc | 150,000 | $2.54M | 0.00% | +150,000 | New |
| Monashee Investment Management LLC | 150,000 | $2.54M | 0.27% | +150,000 | New |
| Eversept Partners, LP | 190,531 | $3.22M | 0.25% | +190,531 | New |
| ArrowMark Colorado Holdings LLC | 300,000 | $5.08M | 0.07% | +300,000 | New |
| Price T Rowe Associates Inc | 486,854 | $8.24M | 0.00% | +486,854 | New |
| Pivotal bioVenture Partners Investment Advisor LLC | 650,695 | $11.0M | 6.54% | +650,695 | New |
| Rock Springs Capital Management LP | 878,667 | $14.9M | 0.48% | +878,667 | New |
| Perceptive Advisors LLC | 1,144,035 | $19.4M | 0.42% | +1,144,035 | New |
| Novo Holdings A/S | 1,150,000 | $19.5M | 0.97% | +1,150,000 | New |
| Federated Hermes, Inc. | 1,158,000 | $19.6M | 0.04% | +1,158,000 | New |
| Vivo Capital, LLC | 1,183,260 | $20.0M | 1.66% | +1,183,260 | New |
| Wellington Management Group LLP | 1,501,428 | $24.8M | 0.00% | +1,501,428 | New |
| Deerfield Management Company, L.P. (Series C) | 1,562,942 | $26.4M | 0.40% | +1,562,942 | New |
| NVP Associates, LLC | 1,838,482 | $31.1M | 17.66% | +1,838,482 | New |
| Fairmount Funds Management LLC | 1,892,806 | $32.0M | 2.60% | +1,892,806 | New |
| FMR LLC | 2,000,000 | $33.8M | 0.00% | +2,000,000 | New |
| NEA Management Company, LLC | 2,613,948 | $44.2M | 2.41% | +2,613,948 | New |
| Sr One Capital Management, LP | 4,911,539 | $83.1M | 16.66% | +4,911,539 | New |